The Biological Clinical Basis of Visceral Leishmaniasis als von
5 Angebote vergleichen
Preise | 2013 | 2014 | 2017 |
---|---|---|---|
Schnitt | € 89,12 | € 88,40 | € 90,54 |
Nachfrage |
1
The Biological and Clinical Basis of Visceral Leishmaniasis (2011)
DE PB NW
ISBN: 9783639374513 bzw. 3639374517, in Deutsch, VDM, Taschenbuch, neu.
Lieferung aus: Schweiz, Versandfertig innert 6 - 9 Tagen.
Adhesion Molecules and Visceral Leishmaniasis, Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN-¿ and TNF-ss. The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. Taschenbuch, 01.09.2011.
Adhesion Molecules and Visceral Leishmaniasis, Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN-¿ and TNF-ss. The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. Taschenbuch, 01.09.2011.
2
The Biological and Clinical Basis of Visceral Leishmaniasis: Adhesion Molecules and Visceral Leishmaniasis (2011)
EN PB NW
ISBN: 9783639374513 bzw. 3639374517, in Englisch, 236 Seiten, VDM Verlag Dr. Müller, Taschenbuch, neu.
جديد من: $73.51 (13 ويقدم)
تستخدم من: $118.76 (3 ويقدم)
إظهار المزيد 16 ويقدم في Amazon.com
Lieferung aus: Vereinigte Staaten von Amerika, Usually ships in 24 hours.
Von Händler/Antiquariat, Amazon.com.
Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN-γ and TNF-β. The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. Paperback, التسمية: VDM Verlag Dr. Müller, VDM Verlag Dr. Müller, مجموعة المنتجات: Book, ونشرت: 2011-09-02, ستوديو: VDM Verlag Dr. Müller, رتبة المبيعات: 11227145.
Von Händler/Antiquariat, Amazon.com.
Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN-γ and TNF-β. The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. Paperback, التسمية: VDM Verlag Dr. Müller, VDM Verlag Dr. Müller, مجموعة المنتجات: Book, ونشرت: 2011-09-02, ستوديو: VDM Verlag Dr. Müller, رتبة المبيعات: 11227145.
3
The Biological and Clinical Basis of Visceral Leishmaniasis - Adhesion Molecules and Visceral Leishmaniasis (2011)
DE PB NW
ISBN: 9783639374513 bzw. 3639374517, in Deutsch, 236 Seiten, VDM Verlag Dr. Müller, Taschenbuch, neu.
Lieferung aus: Deutschland, الشحن المجاني.
Von Händler/Antiquariat, Syndikat Buchdienst, [4235284].
Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN- and TNF- . The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. 2011, Taschenbuch / Paperback, Neuware, 236, Internationaler Versand, Selbstabholung und Barzahlung, PayPal, offene Rechnung, Banküberweisung.
Von Händler/Antiquariat, Syndikat Buchdienst, [4235284].
Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN- and TNF- . The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. 2011, Taschenbuch / Paperback, Neuware, 236, Internationaler Versand, Selbstabholung und Barzahlung, PayPal, offene Rechnung, Banküberweisung.
4
The Biological and Clinical Basis of Visceral Leishmaniasis
DE PB NW
ISBN: 9783639374513 bzw. 3639374517, in Deutsch, 236 Seiten, VDM Verlag, Taschenbuch, neu.
Lieferung aus: Deutschland, الشحن المجاني.
Von Händler/Antiquariat, Mein Buchshop, [4021159].
Neuware - Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN- and TNF- . The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. Taschenbuch, Neuware, 220x150x14 mm, 368g, 236, Internationaler Versand, PayPal, offene Rechnung, Banküberweisung.
Von Händler/Antiquariat, Mein Buchshop, [4021159].
Neuware - Leishmaniasis is prevalent through out the tropical and sub-tropical regions of Africa, Asia, the Mediterranean, Southern Europe (old world) and South and Central America (new world). It is estimated that approximately 12 million people are currently infected and a further 367 million are at risk of acquiring Leishmaniasis in 88 countries, 72 of which are developing countries and 16 of them are among the least developed in the world. The estimated incidence is 2 million new cases each year of which 0.5 million are of VL and 1.5 million are of CL. Immune system plays an important role in protection against all forms of Leishmaniasis. Protection is mediated mainly through the ability of the CD4 cells to converge into Th1 effectors which mainly produce many cytokines such as IL-2, IFN- and TNF- . The need for an immunological strategy to be employed in VL control programme is also felt due to the fact that a large number of VL cases are now becoming resistant and many drugs are now proving to be less effective in the cure of VL patients. This book therefore sheds light on some newer aspects in dealing with Visceral Leishmaniasis. Taschenbuch, Neuware, 220x150x14 mm, 368g, 236, Internationaler Versand, PayPal, offene Rechnung, Banküberweisung.
5
The Biological and Clinical Basis of Visceral Leishmaniasis als von Sukrat Sinha, Shanthy Sundaram, Sanjiva Bimal
DE HC NW
ISBN: 9783639374513 bzw. 3639374517, in Deutsch, VDM Verlag Dr. Müller, Saarbrücken, Deutschland, gebundenes Buch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…